期刊文献+

Raji细胞逃逸NK细胞免疫杀伤机制的初步探讨 被引量:2

Aberrant expression of NKG2D ligands and high expression HLA-Ⅰmolecules may contribute to immune escape of Raji cells from NK cell-mediated immune surveillance of malignant lymphoma
下载PDF
导出
摘要 目的探讨人B细胞淋巴瘤Raji细胞逃逸NK细胞免疫杀伤的机制。方法以K562细胞作为对照,应用LDH释放法检测不同效靶比时同种异体NK细胞杀伤Rail细胞的活性。并分别用PCR方法和流式细胞仪检测K562和Raji细胞MICA/B、ULBP1~3、HLA基因型和分子的表达情况。效靶比20:1时用单抗分别阻断K562和Raji细胞表面MICA、MICB、ULBP1、ULBP2、ULBP3和HLA-Ⅰ类分子,观察NK细胞对其杀伤活性的变化。结果不同效靶比时NK细胞杀伤Raji细胞的活性明显低于杀伤K562细胞的活性,二者之间差异有统计学意义(P〈0.05)。K562细胞表达MICA/B和ULBP1~3基因和分子,不表达HLA—Ⅰ类分子,Raji细胞表达ULBP1~3基因和HLA-Ⅰ类分子,不表达MICA/B和ULBP1~3分子。Rail细胞HLA基因型为A*3、3,B*71、71,Cw3、4。用单抗封闭MICA/B和ULBP1-3分子后,NK细胞对K562细胞的杀伤活性明显降低,对Raji细胞的杀伤活性无明显改变。结论Raji细胞逃逸NK细胞免疫杀伤机制和Raji细胞高表达HLA-Ⅰ类分子,不表达NKG2D的配体MICA/B和ULBP1~3有关。 Objective To explore the mechanism of immune escape of Raji cells from natural killer (NK) cell-mediated immune surveillance of B cell malignant lymphoma. Methods Taking K562-cell as positive control, cytotoxicities of NK cells isolated from 5 healthy vol- unteers against Raji cells were analyzed by LDH releasing assay at different effector-to-target cell (E:T) ratios. The genes and proteins expression of NKG2D ligands on K562 and Raji cell were measured by RT-PCR and flow cytometry, respectively. The genes of HLA- Ⅰ molecules in Raji cell and KIR of NK cell were assayed by PCR-SSCP. In blocking experiments, monoclonal antibodies of HLA- Ⅰ molecule and different NKG2D ligands were added to the target cell at E: T of 20: 1. Results Comparing with K562 cells, the Raji cells resisted NK cell cytolysis. The mRNA genes of ULBP1 - 3 were positive in two tumor cell lines. The mRNA genes of MICA/B was found in K562 cells, not in Raji cells. The HLA- class Ⅰ genotypes of Raji cells were A * 3, 3; B * 71, 71; Cw3, 4. The protein of MICA/B and ULBP1 - 3 were expressed on K562 cell line, but not on Raji cell line; HLA- Ⅰ molecule was found on the surface of Raji cell, but not on K562 cell. In blocking experim- ents, the cytotoxicity of NK cells against K562 cell was partially inhibited but that against Raji cell was not influenced when mAbs of different NKG2D ligands were added; the cytotoxicity of NK cells against Raji cell was obviously improved but that against K562 cell was not influenced when mAb of HLA- Ⅰ molecules was added. Conclusion Aberrant expression of NKG2D ligands and high expression HLA- Ⅰ molecules may contribute to immune escape of Raji cells from natural killer cell-mediated immune surveillance of B cell malignant lymphoma.
出处 《免疫学杂志》 CAS CSCD 北大核心 2008年第4期369-372,共4页 Immunological Journal
关键词 自然杀伤细胞 自然杀伤细胞受体 B细胞淋巴瘤 细胞毒性试验 HLA-Ⅰ类分子 Natural killer cell NK cell receptor B cell lymphoma Cytotoxicity HLA- Ⅰ molecule
  • 相关文献

参考文献10

  • 1Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells [J]. Semin Immunol, 2006, 18 (3) : 145- 150.
  • 2Coudert JD, Held W. The role of the NKG2D receptor for tumor immunity [J]. Semin Cancer Biol, 2006, 16 (5): 333 - 343.
  • 3Hasenkamp J, Borgerding A, Wulf G, et al. Resistance against natural killer cell cytotoxicity : analysis of mechanisms [J]. Scand J Immunol, 2006, 64 (4) : 444- 449.
  • 4Friese MA, Platten M, Lutz SZ, et al. MICA/NKG2D-mediated immunogene therapy of experimental gliomas [J]. Cancer Res, 2003, 63 (24): 8 996-9 006.
  • 5Vilehes C, Parham P. KIR: diverse, rapidly evolving receptors of irmate and adaptive immunity [ J ]. Annu Rev Immunol, 2002, 20 (1): 217-251.
  • 6尹晓林,郭坤元,肖露露.KIR基因的进化、表达与功能[J].免疫学杂志,2004,20(z1):103-105. 被引量:6
  • 7颜卫华,范丽安.HLA-G与移植免疫[J].免疫学杂志,2004,20(z1):1-3. 被引量:2
  • 8Hsu KC, Keever Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes [J]. Blood, 2005, 105 (12): 4 878 - 4 884.
  • 9Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells [J]. Immunol Rev, 2036, 214 (1) : 130- 142.
  • 10Carbone E, Neri P, Mesuraca M, et al. HLA class Ⅰ, NKG2D and natural cytotoxicity receptors regulate muhiple myeloma cell recognition by natural killer cells [J]. Blood, 2005, 105 (1): 251-258.

二级参考文献49

  • 1[11]Shilling HG, Guethlein LA, Cheng NW, et al . Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype [J]. J Immunol, 2002, 168:2 307 -2 315.
  • 2[12]Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes,each with multiple subsets[J]. J Immunol, 2002, 169(9):5 118-5 129.
  • 3[13]Witt CS, Whiteway JM, Warren HS, et al . Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia[J]. Eur J Immunol, 2002,32(1): 18 - 29.
  • 4[14]Witt CS, Dewing C, Sayer DC, et al . Population frequencies and putative haplotypes of the killer cell immunoglobulinlike receptor sequences and evidence for recombination [J].Transplantation, 1999,68(5):1 784- 1 789.
  • 5[15]Vely F, Peyrat M, Couedel C, et al. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after temination of TCR rearrangements[J] .J lmmunol, 2001, 166(4): 2 487 - 2 494.
  • 6[16]Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors [ J ]. Immunity, 1997,7(6) :739 - 751.
  • 7[17]Santourlidis S, Trompeter HI, Weinhold S, et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells[J]. J Immunol, 2002,169(8) :4 253 - 4 261.
  • 8[18]Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity[J]. Annu Rev Immunol,2002,20(1) :217 - 251.
  • 9[19]Winter CC, Gumperz JE, Parham P, et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition[J]. J Immunol,1998,161(2) :571 - 577.
  • 10[20]Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells [ J ]. J Immunol,2004, 172(1): 644-650.

共引文献6

同被引文献15

  • 1Terme M,Ullrich E,D elahaye NF,et al. Natural killer cell-directed therapies: moving from unexpected results to successful strategies [J]. Nat Immunol, 2008,9 (5): 486-494.
  • 2Malmberg K J, Bryceson YT, Carlsten M, et al. NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy [J]. Cancer Immunol Immunother, 2008,57 (10) : 1541-1552.
  • 3Geller MA,Cooley S,Judson PL,et al. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer [J]. Cytotherapy, 2010 Sep 20. [Epub ahead of print].
  • 4Farag SS, Caligiuri MA. Human natural killer cell development and biology [J]. Blood Rev, 2006,20 (3): 123-137.
  • 5Srivastava S,Lundqvist A,Childs RW. Natural killer cell immunotherapy for cancer: a new hope [J]. Cytotherapy, 2008, 10 (8):775-783.
  • 6Berg M, Lundqvist A, McCoy P Jr, et al. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells [J]. Cytotherapy, 2009,11 (3) : 341-355.
  • 7Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells [J]. Blood, 2005,106 (1):376-383.
  • 8Luhm J, Brand JM, Koritke P, et al. Large-scale generation of natural killer lymphocytes for clinical application [J]. Hematother Stem Cell Res, 2002,11 (4) : 651-657.
  • 9de Jong D, Balague PO. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy [ J ]. J Pathol, 2011 , 223(2) : 274-282.
  • 10Hu L, Cao D, Li Y, et al. Resveratrol sensitized leukemia stem cell-like KG-1α cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors [J]. Cancer Biol Ther, 2012,13(7) : 516-526.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部